FDA Warning Letter — Oasis

Case 542153 — FEI 3013993554

The FDA took a Warning Letter action against Oasis on Nov 30, 2017 (Washington, DC). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Oasis
Date
Nov 30, 2017
Fiscal Year
2018
Product Type
Tobacco
Center
CTP
Location
Washington, DC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.